{"id":"fluacizine","rwe":[{"pmid":"31994524","year":"2019","title":"[A 70-year history of tricyclic antidepressants].","finding":"","journal":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","studyType":"Clinical Study"},{"pmid":"4474896","year":"1974","title":"Distribution and action of fluacizine during prolonged administration.","finding":"","journal":"Bulletin of experimental biology and medicine","studyType":"Clinical Study"},{"pmid":"4441683","year":"1974","title":"Effect of fluacizine on the uptake of exogenous noradrenalin.","finding":"","journal":"Bulletin of experimental biology and medicine","studyType":"Clinical Study"},{"pmid":"4153328","year":"1974","title":"Effect of fluacizine on the uptake of exogenous noradrenalin by the isolated rat vas deferens.","finding":"","journal":"Bulletin of experimental biology and medicine","studyType":"Clinical Study"}],"tags":[{"label":"fluacizine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ftoracizine","offLabel":[],"synonyms":["fluacizine","fluoracizine","ftoracizine","phtorazisin"],"timeline":[],"approvals":[],"brandName":"Ftoracizine","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"fluacizine","explanation":"Imagine your body's cells have locks on them, and Ftoracizine is a key that fits into one of those locks. When it binds to the lock, it can either block or enhance the normal functioning of the cell, depending on the specific target and the disease being treated. This can help to restore balance and alleviate symptoms.","oneSentence":"Ftoracizine is thought to work by interacting with a specific molecular target to produce its therapeutic effects.","technicalDetail":"Ftoracizine's exact mechanism of action is unknown, but it is believed to interact with a specific molecular target to produce its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3230","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUACIZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:31:54.450591","biosimilars":[],"competitors":[],"genericName":"fluacizine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"E2M3325B1R","CHEBI":"CHEBI:135625","INN_ID":"2999","UMLSCUI":"C1880797","ChEMBL_ID":"CHEMBL92281","PUBCHEM_CID":"161562","MESH_SUPPLEMENTAL_RECORD_UI":"C001228"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":4,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2019","pmid":"31994524","title":"[A 70-year history of tricyclic antidepressants].","journal":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova"},{"date":"1974 Nov","pmid":"4474896","title":"Distribution and action of fluacizine during prolonged administration.","journal":"Bulletin of experimental biology and medicine"},{"date":"1974 Nov","pmid":"4441683","title":"Effect of fluacizine on the uptake of exogenous noradrenalin.","journal":"Bulletin of experimental biology and medicine"},{"date":"1974 Sep","pmid":"4153328","title":"Effect of fluacizine on the uptake of exogenous noradrenalin by the isolated rat vas deferens.","journal":"Bulletin of experimental biology and medicine"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ftoracizine, also known as Fluacizine, is a small molecule drug in the fluacizine class. Unfortunately, there is limited information available on this compound, including its target, approved indications, and commercial status. As a result, it is difficult to provide a comprehensive summary of its use and safety profile. Further research is needed to determine the potential benefits and risks of Ftoracizine. Its development and current status are unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}